CXCR5 targeting antibody (Centivax)

N/A

Report date: 2025/01/26 18:15:33

Base Information

Drug NameCXCR5 targeting antibody (Centivax)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionC-X-C motif chemokine receptor 5 modulators
TargetsC-X-C motif chemokine receptor 5
Therapy Area/IndicationsAutoimmune DiseasesLupus Erythematosus, SystemicArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCentivax Inc
China Registration ClassN/A

Develop Information

Active CompaniesCentivax Inc
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesLupus Erythematosus, SystemicArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A